Protocol for development and validation of a clinical prediction model for adverse pregnancy outcomes in women with gestational diabetes

• Published in: BMJ open Vol. 10; no. 11; p. e038845
• Main Authors: Cooray, Shamil D., Boyle, Jacqueline A., Soldatos, Georgia, Zamora, Javier, Fernández Félix, Borja M., Allotey, John, Thangaratinam, Shakila, Teede, Helena J.
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group LTD 05.11.2020; BMJ Publishing Group
• Series: Protocol
• Subjects: Australia; Births; Clinical medicine; Decision making; Diabetes and Endocrinology; Diabetes, Gestational - diagnosis; Diabetes, Gestational - epidemiology; Endocrinology; Female; Gestational diabetes; Glucose; Humans; Hyperglycemia; Hypoglycemia; Intervention; New Zealand; Pregnancy; Pregnancy complications; Pregnancy Outcome - epidemiology; Qualitative research; Retrospective Studies; Systematic review; Womens health; Working groups; New Zealand; Australia; diabetes in pregnancy; obstetrics; public health
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2020-038845

IntroductionGestational diabetes (GDM) is a common yet highly heterogeneous condition. The ability to calculate the absolute risk of adverse pregnancy outcomes for an individual woman with GDM would allow preventative and therapeutic interventions to be delivered to women at high-risk, sparing women at low-risk from unnecessary care. The Prediction for Risk-Stratified care for women with GDM (PeRSonal GDM) study will develop, validate and evaluate the clinical utility of a prediction model for adverse pregnancy outcomes in women with GDM.Methods and analysisWe undertook formative research to conceptualise and design the prediction model. Informed by these findings, we will conduct a model development and validation study using a retrospective cohort design with participant data collected as part of routine clinical care across three hospitals. The study will include all pregnancies resulting in births from 1 July 2017 to 31 December 2018 coded for a diagnosis of GDM (estimated sample size 2430 pregnancies). We will use a temporal split-sample development and validation strategy. A multivariable logistic regression model will be fitted. The performance of this model will be assessed, and the validated model will also be evaluated using decision curve analysis. Finally, we will explore modes of model presentation suited to clinical use, including electronic risk calculators.Ethics and disseminationThis study was approved by the Human Research Ethics Committee of Monash Health (RES-19–0000713 L). We will disseminate results via presentations at scientific meetings and publication in peer-reviewed journals.Trial registration detailsSystematic review proceeding this work was registered on PROSPERO (CRD42019115223) and the study was registered on the Australian and New Zealand Clinical Trials Registry (ACTRN12620000915954); Pre-results.